Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study

BACKGROUND: Fibroblast growth factor-23 (FGF-23), a novel marker of bone disease in chronic kidney disease (CKD) has been shown to correlate with vascular calcifications. We aimed to describe the effect of the calcium phosphate product (Ca*P) on FGF-23 concentrations in children and young adults wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasin, Abeer, Liu, Daisy, Chau, Luan, Madrenas, Joaquín, Filler, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598245/
https://www.ncbi.nlm.nih.gov/pubmed/23413976
http://dx.doi.org/10.1186/1471-2369-14-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598245/
https://www.ncbi.nlm.nih.gov/pubmed/23413976
http://dx.doi.org/10.1186/1471-2369-14-39

Ejemplares similares